Offstream
news

---

Changes

1. American company Pfizer and German company BioNTech says that they are on track to being submitted for regulatory review as early as October.
   2020-08-23 15:04:07 (First version)
2. American company Pfizer and German company BioNTech say that they are on track to being submitted for regulatory review as early as October.
   (Current version)

---

Related

The Biden administration announces that the United States has purchased 200 million extra doses of the vaccine developed by Pfizer and BioNTech, including doses intended for children under the age of 12 years old.
2021-07-23

The European Commission signs a third contract with Pfizer and BioNTech to secure 1.8 billion doses of its vaccine.
2021-05-20

The World Health Organization lists the Pfizer-BioNTech vaccine for emergency use.
2020-12-31

Ireland officially begins a vaccination programme against COVID-19 using Pfizer-BioNTech's tozinameran vaccine, with a 79-year-old woman from Dublin becoming the first person to receive the vaccine.
2020-12-29

Switzerland begins a mass vaccination campaign against COVID-19 using the Pfizer-BioNTech vaccine tozinameran. A ninety-year-old woman in Lucerne is the first Swiss citizen to receive the vaccine.
2020-12-23

The Ministry of Public Health approves the authorization of the Pfizer-BioNTech vaccine for emergency use in Qatar.
2020-12-20

Saudi Arabia begins its vaccination campaign a day after it received two shipments of the Pfizer-BioNTech vaccine. More than 150,000 people have registered to receive the vaccine.
2020-12-17

Two health care workers at Bartlett Regional Hospital in Juneau have a severe allergic reaction after being administered Tozinameran, the Pfizer-BioNTech vaccine for COVID-19. Both healthcare workers are expected to recover.
2020-12-16

Prime Minister Lee Hsien Loong says that Singapore has approved the Pfizer-BioNTech vaccine. The country expects to receive shipments of the vaccine by the end of the year and to vaccinate 5.7 million people for free by the third quarter of 2021.
2020-12-14

The European Medicines Agency announces that they will launch a review for vaccines developed by Pfizer and BioNTech.
2020-10-6